Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist
Journal of Translational Internal Medicine · 25.06.2026 · 14 (3) · 481-484
DOI: 10.1515/jtim-2026-0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 04.04.2026. Verfasst von Changpeng Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
- Department of Interventional Radiology, Changzheng Hospital, Naval Medical University, Shanghai, China.
ORCID-Profile: Yong Lin, Weifen Xie
Zitieren
APA
Zhu, C., Dong, W., Liao, H., Lin, Y., & Xie, W. (2026). Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist. Journal of Translational Internal Medicine, 14(3), 481-484. https://doi.org/10.1515/jtim-2026-0012
Vancouver
Zhu C, Dong W, Liao H, Lin Y, Xie W. Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist. Journal of Translational Internal Medicine. 2026;14(3):481-484. doi:10.1515/jtim-2026-0012
BibTeX
@article{Zhu2026,
author = {Zhu, Changpeng and Dong, Weihua and Liao, Huaqiang and Lin, Yong and Xie, Weifen},
title = {Cirrhotic portal hypertension treated with a 5-hydroxytryptamine receptor 1A antagonist},
journal = {Journal of Translational Internal Medicine},
year = {2026},
volume = {14},
number = {3},
pages = {481--484},
doi = {10.1515/jtim-2026-0012}
}
EUVIMED